Prolonged anticoagulant treatment in patients with cancer: Where do we stand?

被引：2
|
作者：
Napolitano, Mariasanta [1 ]
Siragusa, Sergio [1 ]
机构：
[1] Univ Palermo, UOC Ematol Con Trapianto, Dipartimento Biomed Med Interna & Specialist, Palermo, Italy
来源：
THROMBOSIS RESEARCH | 2017年 / 158卷
关键词：
Low molecular weight heparin; Tinzaparin; Cancer associated thrombosis; Recurrences; Bleeding; MOLECULAR-WEIGHT HEPARIN; VENOUS THROMBOEMBOLISM; VEIN THROMBOSIS; TRIAL;
D O I：
10.1016/j.thromres.2017.09.009
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：152 / 153
页数：2
相关论文
共 50 条
  • [21] Where Do We Stand on the Integration of PARP Inhibitors for the Treatment of Breast Cancer?
    Narjust Duma
    Kelly C. Gast
    Grace M. Choong
    Roberto A. Leon-Ferre
    Ciara C. O’Sullivan
    Current Oncology Reports, 2018, 20
  • [22] COOLING WATER TREATMENT - WHERE DO WE STAND
    DONOHUE, JM
    MATERIALS PROTECTION AND PERFORMANCE, 1972, 11 (06): : 19 - &
  • [23] Imaging evaluation of neoadjuvant breast cancer treatment: where do we stand?
    Alvarez-Benito, Marina
    EUROPEAN RADIOLOGY, 2024, : 6271 - 6272
  • [24] Dithiolethiones for cancer chemoprevention: where do we stand?
    Zhang, Yuesheng
    Munday, Rex
    MOLECULAR CANCER THERAPEUTICS, 2008, 7 (11) : 3470 - 3479
  • [25] Biomarkers for cancer cachexia: where do we stand?
    Palus, Sandra
    Springer, Jochen
    JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2020, 11 (06) : 1388 - 1389
  • [26] Magnesium treatment for asthma - Where do we stand?
    Noppen, M
    CHEST, 2002, 122 (02) : 396 - 398
  • [27] Lung cancer in Pakistan, where do we stand?
    Majeed, Farhan Ahmed
    Azeem, Abdul Rehman
    Farhan, Nabeela
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2019, 69 (03) : 405 - 408
  • [28] Marine Compounds and Cancer: Where Do We Stand?
    Dyshlovoy, Sergey A.
    Honecker, Friedemann
    MARINE DRUGS, 2015, 13 (09): : 5657 - 5665
  • [29] Heparins and cancer survival: where do we stand?
    Noble, Simon
    THROMBOSIS RESEARCH, 2014, 133 : S133 - S138
  • [30] Prevention and treatment of stroke: Where do we stand?
    Gibaldi, M
    JOURNAL OF CLINICAL PHARMACOLOGY, 1997, 37 (09): : 784 - 790
12345